Skip to main content
. Author manuscript; available in PMC: 2012 Jan 23.
Published in final edited form as: Am J Med. 2009 Dec;122(12):1142–1149.e1-2. doi: 10.1016/j.amjmed.2009.02.021

Table 3.

Multiple regression analyses for association of exposure to drug burden at year 1 (3a) and the area under the curve for drug burden (AUCDB) from years 1 and 6 (3b), with physical function at year 6 (SPPB Score, Gait Speed (m/s) and Grip Strength (kg)). The parameter estimates, B, tell the amount of change in each functional score that would be predicted by a 1 unit change in the predictor. The t Value and Pr > |t| columns provide the t-value and 2 tailed p-value used in testing the null hypothesis that the parameter estimate is 0. R-Square is the proportion of variance in the functional score which can be predicted from the independent variables. FCI; functional comorbidity index.

Table 3a. Multiple regression for association of Drug Burden Index at baseline (year 1) with functional measures at year 6.

Functional Measure at Year 6

Short Physical Performance Battery Score Usual Gait Speed (m/s) Grip Strength (kg)

Factor B T Pr> ItI B T Pr> ItI B T Pr> ItI
Age −0.09 −6.34 <0.0001 −0.01 −6.29 <0.0001 −0.25 −5.89 <0.0001
Sex (Female) −0.30 −3.52 =0.0004 −0.05 −5.10 <0.0001 −4.20 −11.39 <0.0001
Race (Black) −0.31 −3.38 =0.0007 −0.05 −4.68 <0.0001 −0.13 −0.49 ns
Study Site (Memphis) 0.01 0.17 ns 0.02 1.63 ns −0.14 −0.58 ns
Secondary Education (Absent) −0.11 −1.01 ns −0.03 −2.62 =0.009 0.75 2.43 <0.05
Baseline FCI −0.10 −3.55 =0.0004 −0.01 −4.54 <0.0001 0.05 0.64 ns
Additional comorbidities over 6 years −0.15 −2.65 =0.008 −0.01 −2.06 =0.04 −0.33 −1.98 <0.05
Hospitalization years 1-6 −0.32 −3.79 =0.0002 −0.03 −3.21 =0.001 −0.94 −3.85 =0.0001
Cumulative Anxiety, Depression, Cognitive Impairment −0.26 −4.74 <0.0001 −0.02 −3.79 =0.0002 −0.55 −3.48 =0.0005
Cumulative Sleep Problems −0.01 −0.13 ns −0.01 −0.81 ns −0.04 −0.14 ns
Baseline Functional Measure 0.63 21.47 <0.0001 0.51 22.31 <0.0001 0.64 37.48 <0.0001
Baseline Drug Burden Index −0.29 −2.67 =0.008 −0.04 −3.26 =0.001 −0.56 −1.76 =0.08

Adjusted R2 0.31 0.37 0.73

Table 3B. Multiple regression for association of the area under the Drug Burden Index - time curve (AUCDB) over five years with functional measures at year 6.

Functional Measure at Year 6

Short Physical Performance Battery Score Usual Gait Speed (m/s) Grip Strength (kg)

Factor B T Pr> ItI B T Pr> ItI B T Pr> ItI
Age −0.09 −6.30 <0.0001 −0.01 −6.22 <0.0001 −0.25 −5.91 <0.0001
Sex (Female) −0.31 −3.63 =0.0003 −0.05 −5.21 <0.0001 −4.26 −11.53 <0.0001
Race (Black) −0.31 −3.40 =0.0007 −0.05 −4.69 <0.0001 −0.15 −0.56 ns
Study Site (Memphis) 0.02 0.21 ns 0.02 1.66 ns −0.10 −0.56 ns
Secondary Education (Absent) −0.11 −1.05 ns −0.03 −2.64 =0.008 0.73 2.38 =0.02
FCI at baseline −0.10 −3.54 =0.0004 −0.01 −4.55 <0.0001 0.07 0.82 ns
Additional comorbidities over 6 years −0.15 −2.62 =0.009 −0.01 −2.03 =0.04 −0.33 −1.97 <0.05
Hospitalization years 1-6 −0.31 −3.76 =0.0002 −0.03 −3.19 =0.002 −0.92 −3.78 <0.0005
Cumulative Anxiety, Depression, Cognitive Impairment −0.25 −4.67 <0.0001 −0.02 −3.73 =0.0002 −0.52 −3.31 =0.001
Cumulative Sleep Problems −0.01 −0.10 ns −0.01 −0.79 ns −0.01 −0.04 ns
Baseline Functional Measure 0.63 21.69 <0.0001 0.51 22.26 <0.0001 0.64 37.51 <0.0001
AUCDB −0.08 −2.46 =0.01 −0.01 −2.86 =0.004 −0.27 −2.87 =0.004

Adjusted R2 0.30 0.37 0.73